News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK), Novartis AG (NVS) Get U.S. Grants to Make Vaccines


6/19/2012 7:28:03 AM

Pharmaceutical companies including GlaxoSmithKline PLC and Novartis AG will get government grants to help develop medicines against pandemics and bioterrorist threats, the U.S. government said on Monday. The two drugmakers - among the world's largest vaccine makers - as well as U.S.-based Emergent Biosolutions Inc will work with U.S. universities and smaller biotechnology companies at one of three centers to develop and manufacture the medicines. The U.S. Department of Health and Human Services announced the partnership to ensure enough critical medicines - such as protection against pandemics like influenza or biological attacks like anthrax - are manufactured within U.S. borders.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES